A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update We studied 33,991 patients with a history of breast, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results